# US 2024/0197989 A1 · Systems for out-patient treatment of a patient, and related methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197989 A1
- Document ID: US20240197989A1
- Status: Published application
- Kind: A1
- Application number: 18/287,046
- Filed: 2022-04-27
- Published: 2024-06-20
- Earliest claimed: 2021-04-28
- Assignees: Amgen Inc.; Amgen Research (Munich) GmbH
- Applicants: Amgen Inc.; Amgen Research Munich GmbH
- Inventors: Paul Gordon; Gerhard Zugmaier; Muhammad Faraz Zaman
- Web page: https://patentgrep.com/patent/US20240197989A1

## CPC

- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- G16H 40/63: for local operation
- A61M 5/14248: {of the skin patch type}
- G16H 20/17: delivered via infusion or injection
- G16H 40/67: for remote operation
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- G16H 80/00: ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
- A61M 2205/18: with alarm
- A61M 2205/3303: Using a biosensor
- A61M 2205/3553: remote, e.g. between patient's home and doctor's office
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A system for out-patient treatment with immunotherapy that activates T cells of a patient to fight cancer is provided that may include an infusion pump; a patient wearable device configured to acquire sensor data related to detection of cytokines released by the patient in response to the patient receiving the immunotherapy that activates T cells; and remote wireless communication with a healthcare provider based on the acquired sensor data. A computer-readable medium having computer-readable instructions stored thereon that, when executed by a processor, cause the processor to monitor health of a patient may include a sensor data receiving module that, when executed by a processor, causes the processor to receive sensor data; and a warning data generation module that, when executed by a processor, causes the processor to generate at least one warning based on the sensor data, wherein a content of the sensor data is based on an out-patient treatment that includes an immunotherapy that activates T cells of the patient.

## Claims

### Claim 1

A system for out-patient treatment, the system comprising:
an infusion pump for delivering a therapeutic to a patient;
a wearable device configured to be worn by the patient at least one of: (a) before delivery of the therapeutic and (b) during delivery of the therapeutic, the wearable device comprising one or more sensors configured to acquire sensor data related to detection of patient vital signs; and
a wireless communication module disposed on the wearable device and configured for remote wireless communication with a healthcare provider based on the acquired sensor data.

### Claim 2 (depends on 1)

The system of claim 1, wherein the infusion pump comprises the therapeutic.

### Claim 3 (depends on 1)

The system of claim 1, wherein the therapeutic is known to trigger an immune inflammatory response in the patient, potentially leading to an increased risk factors of (a) cytokine release syndrome (CRS) or (b) neurotoxicity (NT).

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The system of claim 1, wherein the therapeutic comprises at least one of (a) an immunotherapy drug that activates patient T cells to fight cancer, (b) an immunotherapy drug including blinatumomab, and (c) an immunotherapy drug including acepatamab.

### Claim 6

(canceled)

### Claim 7

(canceled)

### Claim 8 (depends on 1)

The system of claim 1, wherein the at least one sensor of the wearable device comprises an optical sensor that is configured to measure oxygen of the patient.

### Claim 9 (depends on 1)

The system of claim 1, wherein the at least one sensor of the wearable device is configured to measure at least one indicator of cytokine release syndrome selected from: (a) heart rate (HR), (b) axillary temperature, (c) respiratory rate (RR), (d) oxygen saturation, and (e) blood pressure (BP).

### Claim 10 (depends on 1)

The system of claim 1, wherein the at least one sensor continuously measures at least one of: (a) heart rate, (b) temperature, (c) respiratory rate, and (d) oxygen saturation.

### Claim 11 (depends on 1)

The system of claim 1, wherein the wireless communication module of the wearable device is configured to at least one of (a) send messages to the healthcare provider in real time, (b) send periodic messages to the healthcare provider based on an interval of a predetermined number of second, minutes, or hours, (c) send periodic messages every ten minutes, (d) send an alarm message when oxygen of the patient drops below a predetermined threshold, and (e) send an alarm if the communication is disrupted.

### Claim 12

(canceled)

### Claim 13

(canceled)

### Claim 14

(canceled)

### Claim 15

(canceled)

### Claim 16 (depends on 1)

The system of claim 1, further comprising an axillary temperature sensor for detecting a temperature of the patient during delivery of the therapeutic, the axillary temperature sensor communicatively coupled to the wearable device.

### Claim 17 (depends on 16)

The system of claim 16, where in the axillary temperature sensor includes a wireless communication module configured to communicate with the wireless communication module of the wearable device.

### Claim 18 (depends on 1)

The system of claim 1, further comprising a blood pressure cuff for detecting a blood pressure of the patient during delivery of the therapeutic, wherein the blood pressure cuff is communicatively coupled to the wearable device.

### Claim 19 (depends on 1)

The system of claim 1, wherein the healthcare provider comprises a mobile device configured for wireless communication with the wireless communication module of the wearable device.

### Claim 20 (depends on 19)

The system of claim 19, further comprising a patient-assigned wireless device comprising a mobile application configured to support audio and/or video communication with the mobile device of the healthcare provider.

### Claim 21

A computer-implemented method for out-patient treatment with immunotherapy that activates T cells of a patient to kill cancer, the method comprising:
receiving, at a processor, sensor data in response to the processor executing a sensor data receiving module; and
generating, using a processor, warning data, based on the sensor data, in response to the processor executing a warning data generation module, wherein a content of the sensor data is based on a likelihood that the immunotherapy will trigger increased risk factors of cytokine release syndrome.

### Claim 22 (depends on 21)

The computer-implemented method as in claim 21, further comprising:
transmitting, using a processor, the sensor data to at least one of (a) a healthcare provider device in response to the processor executing a sensor data transmission module, and (b) to a patient device, wherein the sensor data is representative of vital signs of the patient.

### Claim 23 (depends on 21)

The computer-implemented method of claim 21, further comprising:
transmitting, using a processor, the warning data to a healthcare provider device (a) in response to the processor executing a warning data transmission module or (b) when the sensor data exceeds a threshold value, in response to the processor executing a warning data transmission module.

### Claim 24 (depends on 21)

The computer-implemented method of claim 21, further comprising:
transmitting, using a processor, audio/video data between a patient device and a healthcare provider smartphone via a cellular connection in response to the processor executing an audio/video data transmission module.

### Claim 25

(canceled)

### Claim 26 (depends on 21)

The computer-implemented method of claim 21, further comprising:
transmitting, using a processor, patient-initiated call input data to at least one of: a healthcare provider, or a health management system, in response to the processor executing a patient-initiated call input receiving module.

### Claim 27 (depends on 26)

The computer-implemented method as in claim 26, wherein a healthcare provider phone is configured to emit a loud audible alarm, based on the warning data, at a periodic interval until a health care provider responds.

### Claim 28

(canceled)

### Claim 29 (depends on 21)

The computer-implemented method of claim 21, wherein the sensor data is representative of at least one indicator of cytokine release syndrome selected from: heart rate (HR), axillary temperature, respiratory rate (RR), oxygen saturation, and blood pressure (BP).
